OncoPep
Norm Gretzinger is a Co-Founder and Managing Director for the New York City-based private equity firm EG Capital Group, LLC. Prior to establishing EG Capital, Norm served as head of North American consumer mergers and acquisitions for JP Morgan in New York. Earlier in his career, Norm practiced law as a general practice associate for Sullivan & Cromwell. Norm also serves on the board of Georgia Tech’s Parents Fund for Student Engagement and Well-Being Leadership. Norm received a Bachelor of Commerce at the University of Alberta and a JD from the Columbia School of Law.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
OncoPep
Through targeting multiple tumor-associated antigens with an investigational multi-peptide vaccine and a multi-tumor antigen adoptive (MTAA) T cell therapy, OncoPep’s T cell-focused technologies are designed to be used on their own or in combination with other immunotherapeutics.